GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EZH2
|
ENSG00000106462.6 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EZH2 | hg19_v2_chr7_-_148580563_148580601 | -0.55 | 9.0e-19 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_111781610 | 67.93 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr11_-_111781554 | 54.71 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr11_-_111781454 | 54.60 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr3_+_115342159 | 52.03 |
ENST00000305124.6
|
GAP43
|
growth associated protein 43 |
chr3_+_115342349 | 49.67 |
ENST00000393780.3
|
GAP43
|
growth associated protein 43 |
chr15_+_43885252 | 35.15 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr14_-_60337684 | 32.23 |
ENST00000267484.5
|
RTN1
|
reticulon 1 |
chrX_+_103031421 | 31.50 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
chr15_+_43985084 | 30.99 |
ENST00000434505.1
ENST00000411750.1 |
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr14_-_21490958 | 28.99 |
ENST00000554104.1
|
NDRG2
|
NDRG family member 2 |
chr12_+_79258444 | 28.79 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
chr12_-_45269430 | 28.68 |
ENST00000395487.2
|
NELL2
|
NEL-like 2 (chicken) |
chr3_-_195310802 | 28.41 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr1_+_160097462 | 27.51 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr14_-_21490653 | 26.71 |
ENST00000449431.2
|
NDRG2
|
NDRG family member 2 |
chr3_+_111717511 | 26.34 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr12_+_79258547 | 26.19 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr5_-_73937244 | 25.85 |
ENST00000302351.4
ENST00000510316.1 ENST00000508331.1 |
ENC1
|
ectodermal-neural cortex 1 (with BTB domain) |
chr4_-_16900242 | 25.40 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
chr12_+_66218212 | 25.04 |
ENST00000393578.3
ENST00000425208.2 ENST00000536545.1 ENST00000354636.3 |
HMGA2
|
high mobility group AT-hook 2 |
chr8_-_27115903 | 23.82 |
ENST00000350889.4
ENST00000519997.1 ENST00000519614.1 ENST00000522908.1 ENST00000265770.7 |
STMN4
|
stathmin-like 4 |
chr14_-_21491305 | 23.77 |
ENST00000554531.1
|
NDRG2
|
NDRG family member 2 |
chr8_-_18666360 | 23.38 |
ENST00000286485.8
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr11_-_111782484 | 22.93 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
chr2_-_55277654 | 22.84 |
ENST00000337526.6
ENST00000317610.7 ENST00000357732.4 |
RTN4
|
reticulon 4 |
chr14_-_21490590 | 22.64 |
ENST00000557633.1
|
NDRG2
|
NDRG family member 2 |
chr15_+_43886057 | 22.30 |
ENST00000441322.1
ENST00000413657.2 ENST00000453733.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr11_-_133402410 | 22.18 |
ENST00000524381.1
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
chr13_-_67804445 | 22.03 |
ENST00000456367.1
ENST00000377861.3 ENST00000544246.1 |
PCDH9
|
protocadherin 9 |
chr1_+_169077172 | 21.06 |
ENST00000499679.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr12_-_91576561 | 20.74 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
chr8_+_80523962 | 20.72 |
ENST00000518491.1
|
STMN2
|
stathmin-like 2 |
chr5_+_92919043 | 20.63 |
ENST00000327111.3
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1 |
chrX_+_103031758 | 20.59 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
chr8_-_27468842 | 20.02 |
ENST00000523500.1
|
CLU
|
clusterin |
chr4_-_16900410 | 19.92 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
chr4_-_153457197 | 19.89 |
ENST00000281708.4
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr16_-_29910853 | 19.87 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr15_+_43809797 | 19.51 |
ENST00000399453.1
ENST00000300231.5 |
MAP1A
|
microtubule-associated protein 1A |
chr4_+_158141806 | 19.49 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr4_-_16900184 | 19.47 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
chr14_-_21490417 | 18.99 |
ENST00000556366.1
|
NDRG2
|
NDRG family member 2 |
chr4_+_158141843 | 18.97 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr1_-_177134024 | 18.92 |
ENST00000367654.3
|
ASTN1
|
astrotactin 1 |
chr2_-_55277692 | 18.83 |
ENST00000394611.2
|
RTN4
|
reticulon 4 |
chr5_+_140749803 | 18.77 |
ENST00000576222.1
|
PCDHGB3
|
protocadherin gamma subfamily B, 3 |
chr4_-_16900217 | 18.57 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
chr6_-_74161977 | 18.36 |
ENST00000370318.1
ENST00000370315.3 |
MB21D1
|
Mab-21 domain containing 1 |
chr14_-_21270995 | 18.33 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr4_+_156588249 | 18.18 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chrX_-_13835461 | 18.03 |
ENST00000316715.4
ENST00000356942.5 |
GPM6B
|
glycoprotein M6B |
chr17_-_7123021 | 17.92 |
ENST00000399510.2
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chr5_-_146461027 | 17.86 |
ENST00000394410.2
ENST00000508267.1 ENST00000504198.1 |
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr1_-_57045228 | 17.68 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr7_-_124405681 | 17.38 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
chr4_+_158141899 | 17.27 |
ENST00000264426.9
ENST00000506284.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr1_-_156399184 | 17.17 |
ENST00000368243.1
ENST00000357975.4 ENST00000310027.5 ENST00000400991.2 |
C1orf61
|
chromosome 1 open reading frame 61 |
chrX_+_69282303 | 17.10 |
ENST00000338352.2
|
OTUD6A
|
OTU domain containing 6A |
chr3_+_111717600 | 17.07 |
ENST00000273368.4
|
TAGLN3
|
transgelin 3 |
chr12_+_175930 | 16.60 |
ENST00000538872.1
ENST00000326261.4 |
IQSEC3
|
IQ motif and Sec7 domain 3 |
chr12_-_91576429 | 16.53 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
chr12_+_7167980 | 16.52 |
ENST00000360817.5
ENST00000402681.3 |
C1S
|
complement component 1, s subcomponent |
chr15_+_78730622 | 16.51 |
ENST00000560440.1
|
IREB2
|
iron-responsive element binding protein 2 |
chr3_+_147127142 | 16.48 |
ENST00000282928.4
|
ZIC1
|
Zic family member 1 |
chr14_-_45431091 | 16.48 |
ENST00000579157.1
ENST00000396128.4 ENST00000556500.1 |
KLHL28
|
kelch-like family member 28 |
chr1_+_50574585 | 16.47 |
ENST00000371824.1
ENST00000371823.4 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr19_-_49149553 | 16.24 |
ENST00000084798.4
|
CA11
|
carbonic anhydrase XI |
chr15_+_43985725 | 16.21 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr1_-_177133818 | 16.13 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
chr16_-_21289627 | 16.01 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
chr16_-_31085514 | 15.80 |
ENST00000300849.4
|
ZNF668
|
zinc finger protein 668 |
chr1_-_145076186 | 15.55 |
ENST00000369348.3
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr12_-_50294033 | 15.50 |
ENST00000552669.1
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr5_-_35230434 | 15.43 |
ENST00000504500.1
|
PRLR
|
prolactin receptor |
chr7_-_38671098 | 15.20 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
chr6_+_29624862 | 15.13 |
ENST00000376894.4
|
MOG
|
myelin oligodendrocyte glycoprotein |
chr3_+_111718036 | 14.75 |
ENST00000455401.2
|
TAGLN3
|
transgelin 3 |
chr6_+_29624898 | 14.62 |
ENST00000396704.3
ENST00000483013.1 ENST00000490427.1 ENST00000416766.2 ENST00000376891.4 ENST00000376898.3 ENST00000396701.2 ENST00000494692.1 ENST00000431798.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
chr9_+_87284622 | 14.60 |
ENST00000395882.1
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr1_+_209859510 | 14.55 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr1_+_65775204 | 14.29 |
ENST00000371069.4
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr6_+_29624758 | 14.26 |
ENST00000376917.3
ENST00000376902.3 ENST00000533330.2 ENST00000376888.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
chr1_+_2005425 | 14.10 |
ENST00000461106.2
|
PRKCZ
|
protein kinase C, zeta |
chr1_-_182361327 | 14.08 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chr18_-_40695604 | 13.97 |
ENST00000590910.1
ENST00000326695.5 ENST00000589109.1 ENST00000282028.4 |
RIT2
|
Ras-like without CAAX 2 |
chr12_-_45270151 | 13.96 |
ENST00000429094.2
|
NELL2
|
NEL-like 2 (chicken) |
chr14_+_45431379 | 13.90 |
ENST00000361577.3
ENST00000361462.2 ENST00000382233.2 |
FAM179B
|
family with sequence similarity 179, member B |
chr11_+_27062272 | 13.89 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr13_+_113633620 | 13.85 |
ENST00000421756.1
ENST00000375601.3 |
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
chr1_+_2036149 | 13.75 |
ENST00000482686.1
ENST00000400920.1 ENST00000486681.1 |
PRKCZ
|
protein kinase C, zeta |
chr8_-_27115931 | 13.64 |
ENST00000523048.1
|
STMN4
|
stathmin-like 4 |
chr5_+_36608422 | 13.63 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr19_-_42498231 | 13.62 |
ENST00000602133.1
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr12_-_45270077 | 13.56 |
ENST00000551601.1
ENST00000549027.1 ENST00000452445.2 |
NELL2
|
NEL-like 2 (chicken) |
chr1_+_2004901 | 13.52 |
ENST00000400921.2
|
PRKCZ
|
protein kinase C, zeta |
chr19_+_35630926 | 13.48 |
ENST00000588081.1
ENST00000589121.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr1_+_54519242 | 13.42 |
ENST00000234827.1
|
TCEANC2
|
transcription elongation factor A (SII) N-terminal and central domain containing 2 |
chr2_+_210288760 | 13.42 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr7_-_100844193 | 13.32 |
ENST00000440203.2
ENST00000379423.3 ENST00000223114.4 |
MOGAT3
|
monoacylglycerol O-acyltransferase 3 |
chr1_-_182360918 | 13.30 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
chr12_-_91576750 | 13.14 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
chr7_-_137028534 | 13.10 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
chr5_+_161275320 | 13.09 |
ENST00000437025.2
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
chr4_+_156588115 | 12.82 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr18_-_53177984 | 12.82 |
ENST00000543082.1
|
TCF4
|
transcription factor 4 |
chr1_-_163172625 | 12.68 |
ENST00000527988.1
ENST00000531476.1 ENST00000530507.1 |
RGS5
|
regulator of G-protein signaling 5 |
chr7_-_22233442 | 12.65 |
ENST00000401957.2
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr22_-_50524298 | 12.48 |
ENST00000311597.5
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
chr9_+_124062071 | 12.39 |
ENST00000373818.4
|
GSN
|
gelsolin |
chr12_+_101988627 | 12.38 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr7_+_86273700 | 12.18 |
ENST00000546348.1
|
GRM3
|
glutamate receptor, metabotropic 3 |
chr6_+_19837592 | 12.07 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
chr13_-_80915059 | 11.98 |
ENST00000377104.3
|
SPRY2
|
sprouty homolog 2 (Drosophila) |
chr2_-_68384603 | 11.97 |
ENST00000406245.2
ENST00000409164.1 ENST00000295121.6 |
WDR92
|
WD repeat domain 92 |
chr16_-_1020954 | 11.89 |
ENST00000543238.1
ENST00000539379.1 ENST00000399843.2 ENST00000262301.11 |
LMF1
|
lipase maturation factor 1 |
chr1_+_156589051 | 11.81 |
ENST00000255039.1
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2 |
chr7_-_31380502 | 11.77 |
ENST00000297142.3
|
NEUROD6
|
neuronal differentiation 6 |
chr13_-_53422640 | 11.71 |
ENST00000338862.4
ENST00000377942.3 |
PCDH8
|
protocadherin 8 |
chr4_-_46911223 | 11.69 |
ENST00000396533.1
|
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
chr4_+_71587669 | 11.42 |
ENST00000381006.3
ENST00000226328.4 |
RUFY3
|
RUN and FYVE domain containing 3 |
chr19_+_35783047 | 11.39 |
ENST00000595791.1
ENST00000597035.1 ENST00000537831.2 |
MAG
|
myelin associated glycoprotein |
chr5_-_11588907 | 11.21 |
ENST00000513598.1
ENST00000503622.1 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr20_-_62130474 | 11.09 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr1_+_151043070 | 11.05 |
ENST00000368918.3
ENST00000368917.1 |
GABPB2
|
GA binding protein transcription factor, beta subunit 2 |
chr10_+_18629628 | 11.04 |
ENST00000377329.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr2_-_55277436 | 10.99 |
ENST00000354474.6
|
RTN4
|
reticulon 4 |
chr20_-_52687059 | 10.87 |
ENST00000371435.2
ENST00000395961.3 |
BCAS1
|
breast carcinoma amplified sequence 1 |
chr6_-_167276033 | 10.67 |
ENST00000503859.1
ENST00000506565.1 |
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
chr16_+_29911864 | 10.66 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
chr11_-_132813566 | 10.65 |
ENST00000331898.7
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
chr16_+_66914264 | 10.64 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr16_+_7382745 | 10.64 |
ENST00000436368.2
ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr2_-_50574856 | 10.61 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
chrX_+_102631248 | 10.57 |
ENST00000361298.4
ENST00000372645.3 ENST00000372635.1 |
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr5_-_20575959 | 10.56 |
ENST00000507958.1
|
CDH18
|
cadherin 18, type 2 |
chr7_-_137028498 | 10.56 |
ENST00000393083.2
|
PTN
|
pleiotrophin |
chr16_+_31085714 | 10.53 |
ENST00000300850.5
ENST00000564189.1 ENST00000428260.1 |
ZNF646
|
zinc finger protein 646 |
chr17_+_26684604 | 10.52 |
ENST00000292114.3
ENST00000509083.1 |
TMEM199
|
transmembrane protein 199 |
chr15_-_90892669 | 10.51 |
ENST00000412799.2
|
GABARAPL3
|
GABA(A) receptors associated protein like 3, pseudogene |
chr1_+_154193325 | 10.48 |
ENST00000428931.1
ENST00000441890.1 ENST00000271877.7 ENST00000412596.1 ENST00000368504.1 ENST00000437652.1 |
UBAP2L
|
ubiquitin associated protein 2-like |
chr6_+_31982539 | 10.42 |
ENST00000435363.2
ENST00000425700.2 |
C4B
|
complement component 4B (Chido blood group) |
chr15_-_88799948 | 10.41 |
ENST00000394480.2
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr12_+_6930813 | 10.38 |
ENST00000428545.2
|
GPR162
|
G protein-coupled receptor 162 |
chr18_+_29171689 | 10.37 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr11_-_115630900 | 10.33 |
ENST00000537070.1
ENST00000499809.1 ENST00000514294.2 ENST00000535683.1 |
LINC00900
|
long intergenic non-protein coding RNA 900 |
chr2_-_55277512 | 10.29 |
ENST00000402434.2
|
RTN4
|
reticulon 4 |
chrX_-_34675391 | 10.27 |
ENST00000275954.3
|
TMEM47
|
transmembrane protein 47 |
chr7_-_143059780 | 10.23 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr10_-_81205373 | 10.18 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr6_+_126240442 | 10.17 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
chr7_+_129251531 | 10.16 |
ENST00000393232.1
ENST00000353868.4 ENST00000539636.1 ENST00000454688.1 ENST00000223190.4 ENST00000311967.2 |
NRF1
|
nuclear respiratory factor 1 |
chr1_+_233749739 | 10.02 |
ENST00000366621.3
|
KCNK1
|
potassium channel, subfamily K, member 1 |
chr8_+_21916680 | 9.96 |
ENST00000358242.3
ENST00000415253.1 |
DMTN
|
dematin actin binding protein |
chr6_+_123100620 | 9.96 |
ENST00000368444.3
|
FABP7
|
fatty acid binding protein 7, brain |
chr5_-_24645078 | 9.86 |
ENST00000264463.4
|
CDH10
|
cadherin 10, type 2 (T2-cadherin) |
chr8_+_21916710 | 9.82 |
ENST00000523266.1
ENST00000519907.1 |
DMTN
|
dematin actin binding protein |
chr2_-_69870835 | 9.79 |
ENST00000409085.4
ENST00000406297.3 |
AAK1
|
AP2 associated kinase 1 |
chr16_-_1020849 | 9.74 |
ENST00000568897.1
|
LMF1
|
lipase maturation factor 1 |
chr4_+_24797085 | 9.73 |
ENST00000382120.3
|
SOD3
|
superoxide dismutase 3, extracellular |
chr6_-_110501200 | 9.71 |
ENST00000392586.1
ENST00000419252.1 ENST00000392589.1 ENST00000392588.1 ENST00000359451.2 |
WASF1
|
WAS protein family, member 1 |
chr10_-_73848764 | 9.66 |
ENST00000317376.4
ENST00000412663.1 |
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr7_-_143059845 | 9.64 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr5_-_11589131 | 9.61 |
ENST00000511377.1
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr3_-_194991876 | 9.54 |
ENST00000310380.6
|
XXYLT1
|
xyloside xylosyltransferase 1 |
chr12_+_113376249 | 9.50 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr10_-_73848086 | 9.50 |
ENST00000536168.1
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr2_+_210517895 | 9.37 |
ENST00000447185.1
|
MAP2
|
microtubule-associated protein 2 |
chr19_-_10333842 | 9.34 |
ENST00000317726.4
|
CTD-2369P2.2
|
CTD-2369P2.2 |
chr12_+_101988774 | 9.34 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr3_-_9291063 | 9.27 |
ENST00000383836.3
|
SRGAP3
|
SLIT-ROBO Rho GTPase activating protein 3 |
chr2_-_69870747 | 9.25 |
ENST00000409068.1
|
AAK1
|
AP2 associated kinase 1 |
chr17_-_36956155 | 9.23 |
ENST00000269554.3
|
PIP4K2B
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
chr6_-_116601044 | 9.22 |
ENST00000368608.3
|
TSPYL1
|
TSPY-like 1 |
chr2_+_45168875 | 9.21 |
ENST00000260653.3
|
SIX3
|
SIX homeobox 3 |
chr2_-_241737128 | 9.14 |
ENST00000404283.3
|
KIF1A
|
kinesin family member 1A |
chr22_-_36236623 | 9.12 |
ENST00000405409.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr11_-_66496430 | 9.07 |
ENST00000533211.1
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2 |
chr11_+_131240373 | 8.99 |
ENST00000374791.3
ENST00000436745.1 |
NTM
|
neurotrimin |
chr6_+_43543864 | 8.90 |
ENST00000372236.4
ENST00000535400.1 |
POLH
|
polymerase (DNA directed), eta |
chr6_-_110500905 | 8.79 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
chr18_-_52989525 | 8.78 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr1_-_72748417 | 8.78 |
ENST00000357731.5
|
NEGR1
|
neuronal growth regulator 1 |
chr5_+_140345820 | 8.76 |
ENST00000289269.5
|
PCDHAC2
|
protocadherin alpha subfamily C, 2 |
chr11_-_5255696 | 8.68 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
chr17_+_57232690 | 8.66 |
ENST00000262293.4
|
PRR11
|
proline rich 11 |
chr12_+_121088291 | 8.54 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
chr2_+_173686303 | 8.49 |
ENST00000397087.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr3_-_47619623 | 8.43 |
ENST00000456150.1
|
CSPG5
|
chondroitin sulfate proteoglycan 5 (neuroglycan C) |
chr1_+_17906970 | 8.42 |
ENST00000375415.1
|
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr11_+_76092353 | 8.42 |
ENST00000530460.1
ENST00000321844.4 |
RP11-111M22.2
|
Homo sapiens putative uncharacterized protein FLJ37770-like (LOC100506127), mRNA. |
chr11_-_117166276 | 8.37 |
ENST00000510630.1
ENST00000392937.6 |
BACE1
|
beta-site APP-cleaving enzyme 1 |
chr12_+_6930703 | 8.36 |
ENST00000311268.3
|
GPR162
|
G protein-coupled receptor 162 |
chrX_+_70316005 | 8.36 |
ENST00000374259.3
|
FOXO4
|
forkhead box O4 |
chr18_-_52969844 | 8.34 |
ENST00000561831.3
|
TCF4
|
transcription factor 4 |
chr5_-_146258291 | 8.28 |
ENST00000394411.4
ENST00000453001.1 |
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr19_-_51920952 | 8.10 |
ENST00000356298.5
ENST00000339313.5 ENST00000529627.1 ENST00000439889.2 ENST00000353836.5 ENST00000432469.2 |
SIGLEC10
|
sialic acid binding Ig-like lectin 10 |
chr20_+_17207665 | 8.08 |
ENST00000536609.1
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
chr4_-_87028478 | 8.04 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
chr5_+_112227311 | 8.03 |
ENST00000391338.1
|
ZRSR1
|
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 1 |
chr2_-_122407007 | 7.95 |
ENST00000263710.4
ENST00000455322.2 ENST00000397587.3 ENST00000541377.1 |
CLASP1
|
cytoplasmic linker associated protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.3 | 55.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
10.9 | 196.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
10.9 | 108.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
8.4 | 25.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
7.9 | 23.7 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
7.6 | 121.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
7.3 | 44.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
7.3 | 51.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
7.0 | 63.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
6.9 | 41.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
6.8 | 27.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
5.7 | 17.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
5.3 | 26.7 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
5.2 | 20.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
4.5 | 53.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
4.5 | 26.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
4.4 | 13.3 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
4.3 | 47.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
4.0 | 56.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
4.0 | 12.0 | GO:0060437 | lung growth(GO:0060437) |
3.9 | 94.6 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
3.5 | 7.0 | GO:0007497 | posterior midgut development(GO:0007497) |
3.5 | 10.4 | GO:0048687 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
3.4 | 23.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
3.3 | 19.8 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.3 | 26.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.2 | 22.5 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
3.2 | 6.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
3.1 | 15.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
3.1 | 24.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
3.1 | 9.2 | GO:0021798 | neuroblast differentiation(GO:0014016) forebrain dorsal/ventral pattern formation(GO:0021798) regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
2.9 | 14.6 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
2.9 | 25.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.8 | 8.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
2.8 | 30.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.7 | 35.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
2.7 | 10.6 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
2.6 | 2.6 | GO:0010463 | positive regulation of mesenchymal cell proliferation(GO:0002053) mesenchymal cell proliferation(GO:0010463) regulation of mesenchymal cell proliferation(GO:0010464) |
2.5 | 5.0 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.5 | 69.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
2.5 | 12.4 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
2.4 | 9.6 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
2.4 | 64.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.4 | 11.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
2.4 | 16.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
2.3 | 6.9 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
2.3 | 6.8 | GO:1905072 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter urothelium development(GO:0072190) ureter epithelial cell differentiation(GO:0072192) ureter morphogenesis(GO:0072197) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
2.3 | 11.3 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.2 | 13.5 | GO:1903278 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
2.2 | 6.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
2.1 | 8.6 | GO:0048807 | ectoderm and mesoderm interaction(GO:0007499) female genitalia morphogenesis(GO:0048807) |
2.1 | 21.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.1 | 10.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
2.1 | 8.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
2.0 | 15.7 | GO:0015671 | oxygen transport(GO:0015671) |
1.9 | 36.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.9 | 28.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.9 | 5.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.9 | 5.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.9 | 5.6 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
1.8 | 11.0 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.8 | 12.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.8 | 18.0 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.8 | 10.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.8 | 5.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
1.7 | 10.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.7 | 7.0 | GO:0007525 | somatic muscle development(GO:0007525) |
1.7 | 17.4 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.7 | 6.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.7 | 65.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.7 | 6.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.6 | 24.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.6 | 8.1 | GO:0030070 | insulin processing(GO:0030070) |
1.6 | 14.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.6 | 11.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.6 | 3.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.5 | 1.5 | GO:0003018 | vascular process in circulatory system(GO:0003018) regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
1.5 | 4.5 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.5 | 4.5 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.5 | 4.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.5 | 1.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
1.5 | 5.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.4 | 4.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
1.4 | 12.5 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
1.4 | 4.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.4 | 12.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.4 | 2.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.3 | 6.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
1.3 | 16.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
1.3 | 2.6 | GO:0035962 | response to interleukin-13(GO:0035962) |
1.3 | 1.3 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
1.2 | 6.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
1.2 | 2.5 | GO:0015793 | glycerol transport(GO:0015793) |
1.2 | 8.5 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
1.2 | 4.9 | GO:0019086 | late viral transcription(GO:0019086) |
1.2 | 15.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.2 | 4.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.2 | 38.0 | GO:0008038 | neuron recognition(GO:0008038) |
1.2 | 7.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.2 | 19.8 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
1.1 | 4.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.1 | 4.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
1.1 | 4.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) response to methionine(GO:1904640) |
1.1 | 11.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.1 | 14.4 | GO:0006071 | glycerol metabolic process(GO:0006071) |
1.1 | 2.2 | GO:0048867 | stem cell fate determination(GO:0048867) |
1.1 | 3.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.1 | 2.1 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
1.1 | 4.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.0 | 36.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
1.0 | 4.1 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
1.0 | 9.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.0 | 8.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 8.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.0 | 7.0 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
1.0 | 4.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.0 | 2.9 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.9 | 4.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.9 | 5.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.9 | 5.6 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.9 | 3.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.9 | 2.8 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.9 | 6.3 | GO:0045007 | depurination(GO:0045007) |
0.9 | 3.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.9 | 2.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.9 | 3.5 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.9 | 2.6 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
0.9 | 6.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.9 | 3.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.8 | 5.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.8 | 5.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.8 | 4.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.8 | 4.2 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.8 | 1.7 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.8 | 19.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.8 | 2.5 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.8 | 5.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.8 | 7.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.8 | 0.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 4.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 3.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.8 | 5.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 10.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.8 | 3.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 4.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.7 | 6.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.7 | 2.2 | GO:0071812 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.7 | 3.6 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.7 | 10.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.7 | 5.7 | GO:0071363 | cellular response to growth factor stimulus(GO:0071363) |
0.7 | 113.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.1 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.7 | 3.5 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.7 | 4.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.7 | 6.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 16.5 | GO:0007628 | adult walking behavior(GO:0007628) |
0.7 | 2.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.7 | 9.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 3.3 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.7 | 9.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.7 | 3.3 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.7 | 2.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.7 | 10.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.7 | 13.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.6 | 3.8 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 1.9 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.6 | 7.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.6 | 1.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.6 | 3.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 | 1.8 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.6 | 14.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.6 | 4.0 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.6 | 3.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 2.3 | GO:0015811 | L-cystine transport(GO:0015811) |
0.6 | 1.7 | GO:0045726 | regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) |
0.6 | 12.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.6 | 5.6 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.6 | 1.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.5 | 10.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 4.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 1.6 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.5 | 10.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.5 | 3.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.5 | 11.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.5 | 8.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 1.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 3.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.5 | 20.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 2.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 10.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.4 | 2.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.4 | 5.8 | GO:0060736 | prostate gland growth(GO:0060736) |
0.4 | 8.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 2.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 2.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 15.8 | GO:0097484 | dendrite extension(GO:0097484) |
0.4 | 1.3 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.4 | 3.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 6.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 2.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 1.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 5.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 4.3 | GO:0043586 | tongue development(GO:0043586) |
0.4 | 4.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 9.1 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.4 | 3.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 2.6 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.4 | 1.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 7.9 | GO:0006833 | water transport(GO:0006833) |
0.4 | 1.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 9.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 4.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 17.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.3 | 3.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.3 | 5.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 2.4 | GO:0048681 | negative regulation of myelination(GO:0031642) negative regulation of axon regeneration(GO:0048681) |
0.3 | 2.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 4.7 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.3 | 1.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 43.4 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.3 | 1.0 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.3 | 2.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 3.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 2.7 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.3 | 0.9 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 1.5 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.3 | 0.3 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.3 | 3.3 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.3 | 2.7 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.3 | 4.4 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.3 | 2.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.3 | 0.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 4.7 | GO:0010927 | cellular component assembly involved in morphogenesis(GO:0010927) |
0.3 | 1.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.3 | 2.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.1 | GO:0003335 | corneocyte development(GO:0003335) |
0.3 | 6.2 | GO:0001502 | cartilage condensation(GO:0001502) |
0.3 | 14.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 0.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.3 | 4.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 5.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.3 | 6.6 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.3 | 4.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 1.6 | GO:1903506 | regulation of nucleic acid-templated transcription(GO:1903506) regulation of RNA biosynthetic process(GO:2001141) |
0.3 | 0.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 3.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.3 | 5.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 4.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.3 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 4.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.3 | 0.8 | GO:0051941 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.3 | 6.3 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 35.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 1.0 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 2.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.9 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.2 | 2.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 3.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 10.6 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.2 | 1.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 1.6 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 1.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 11.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 5.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 12.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 2.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 5.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 3.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 5.0 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 5.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 6.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 6.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 3.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 8.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 3.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 3.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 12.9 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 3.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 5.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 8.5 | GO:0007517 | muscle organ development(GO:0007517) |
0.2 | 0.6 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 9.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 4.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 4.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 3.4 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 1.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.8 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 4.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 16.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 3.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 3.3 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 1.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 1.8 | GO:0051497 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 2.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 4.1 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 2.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.6 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.7 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.1 | 1.5 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 4.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 0.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.2 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 2.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 3.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 1.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 2.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 1.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 1.1 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
0.1 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.2 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.3 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 1.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 2.1 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.6 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 4.9 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.7 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.0 | 1.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 1.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 2.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.0 | 1.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.6 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.9 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 0.7 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 7.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 1.3 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.5 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.7 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.5 | 108.8 | GO:0032584 | growth cone membrane(GO:0032584) |
13.1 | 210.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
11.1 | 55.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
11.0 | 55.0 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
5.2 | 41.4 | GO:0045179 | apical cortex(GO:0045179) |
4.7 | 14.0 | GO:0097447 | dendritic tree(GO:0097447) |
4.4 | 26.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
4.1 | 81.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
3.8 | 26.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
3.8 | 11.4 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
3.6 | 50.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
3.2 | 12.8 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
3.1 | 63.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.5 | 22.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
2.4 | 7.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.0 | 10.0 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.8 | 11.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.8 | 34.3 | GO:0097386 | glial cell projection(GO:0097386) |
1.8 | 43.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.8 | 21.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.7 | 3.3 | GO:0044308 | axonal spine(GO:0044308) |
1.6 | 8.0 | GO:0089701 | U2AF(GO:0089701) |
1.6 | 6.2 | GO:0031673 | H zone(GO:0031673) |
1.5 | 3.0 | GO:0045298 | tubulin complex(GO:0045298) |
1.4 | 30.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.4 | 20.0 | GO:0042583 | chromaffin granule(GO:0042583) |
1.3 | 12.5 | GO:0031209 | SCAR complex(GO:0031209) |
1.2 | 13.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.1 | 11.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.1 | 214.0 | GO:0030426 | growth cone(GO:0030426) |
1.0 | 5.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 20.8 | GO:0032982 | myosin filament(GO:0032982) |
0.9 | 11.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 12.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 3.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.8 | 2.3 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.8 | 10.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.7 | 3.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.7 | 4.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.7 | 10.7 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 2.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 6.3 | GO:0044297 | cell body(GO:0044297) |
0.6 | 8.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 1.8 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.6 | 5.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 3.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.6 | 4.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.6 | 40.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.6 | 12.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.6 | 10.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.5 | 4.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 2.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.5 | 2.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 64.3 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 8.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.5 | 4.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 7.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.4 | 4.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 2.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 2.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 1.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.4 | 14.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 3.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 29.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 91.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 5.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 1.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 17.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 51.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 4.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 4.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 2.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 3.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 2.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 10.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 5.3 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 8.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 11.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 3.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 6.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 8.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 4.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 9.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 2.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 6.4 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 4.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 57.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 19.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.2 | 12.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 2.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 19.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 2.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 9.2 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 6.8 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 10.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 9.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 10.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 4.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 6.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 5.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 7.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 3.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 2.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 20.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 2.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 6.7 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 2.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 5.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 1.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 2.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 6.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 18.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 6.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 2.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 2.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 2.2 | GO:0098794 | postsynapse(GO:0098794) |
0.0 | 1.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 32.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 3.6 | GO:0005814 | centriole(GO:0005814) |
0.0 | 2.9 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 7.9 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.0 | 55.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
10.1 | 101.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
7.7 | 23.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
7.6 | 83.4 | GO:0030274 | LIM domain binding(GO:0030274) |
7.5 | 22.5 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
6.8 | 27.4 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
5.9 | 23.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
5.9 | 47.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
5.8 | 69.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
5.6 | 172.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
5.3 | 26.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
5.3 | 21.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
4.9 | 14.6 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
4.7 | 18.8 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
4.4 | 13.3 | GO:0035501 | MH1 domain binding(GO:0035501) |
4.4 | 13.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
4.3 | 52.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
4.1 | 65.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
3.3 | 26.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
3.1 | 9.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.1 | 18.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
2.9 | 14.6 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
2.8 | 8.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
2.8 | 11.0 | GO:0043515 | kinetochore binding(GO:0043515) |
2.6 | 13.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
2.6 | 12.8 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
2.5 | 20.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.4 | 12.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
2.3 | 7.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
2.3 | 29.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
2.3 | 29.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.2 | 6.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
2.1 | 27.3 | GO:0031432 | titin binding(GO:0031432) |
2.0 | 8.0 | GO:0030305 | heparanase activity(GO:0030305) |
2.0 | 41.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.9 | 13.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.9 | 9.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.9 | 5.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.8 | 10.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.8 | 7.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.8 | 43.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.8 | 12.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.8 | 5.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
1.7 | 17.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.7 | 5.0 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.7 | 21.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.7 | 5.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.6 | 8.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.6 | 6.3 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
1.6 | 4.7 | GO:0051373 | FATZ binding(GO:0051373) |
1.5 | 12.4 | GO:0030172 | troponin C binding(GO:0030172) |
1.5 | 4.5 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
1.4 | 5.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.4 | 8.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.4 | 36.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.4 | 11.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.3 | 6.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.3 | 8.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.3 | 5.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.3 | 10.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.3 | 10.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.3 | 10.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.2 | 2.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.2 | 24.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.2 | 30.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.2 | 26.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.2 | 10.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
1.1 | 3.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
1.1 | 9.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.1 | 11.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.1 | 3.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.1 | 6.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 3.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
1.1 | 9.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.1 | 14.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.1 | 7.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.1 | 4.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.0 | 4.1 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
1.0 | 7.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 5.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.0 | 16.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.9 | 2.8 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.9 | 5.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.9 | 11.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.9 | 18.0 | GO:0005112 | Notch binding(GO:0005112) |
0.9 | 8.6 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.8 | 15.6 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.8 | 2.5 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.8 | 2.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.8 | 54.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.8 | 4.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.8 | 7.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.8 | 10.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 4.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) peptidyl-dipeptidase activity(GO:0008241) |
0.8 | 3.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.7 | 5.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.7 | 4.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.7 | 4.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.7 | 8.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 7.9 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.6 | 5.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 8.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 6.0 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.6 | 2.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 57.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 9.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 5.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.6 | 5.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.6 | 16.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.5 | 4.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 2.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 1.6 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.5 | 17.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 2.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 4.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 3.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.5 | 6.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 6.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 3.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 4.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 4.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.4 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 5.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 2.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 4.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 11.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 4.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 10.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 6.3 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.4 | 20.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 3.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 2.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.4 | 2.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.4 | 1.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 17.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.3 | 3.8 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 6.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 5.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 2.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.3 | 7.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 7.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.0 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.3 | 3.5 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 6.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.9 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 7.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 15.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 6.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.3 | 1.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 3.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 2.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 10.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 2.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 4.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 6.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 20.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.3 | 3.0 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 2.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 2.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 2.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 4.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 4.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 23.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 8.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 2.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 5.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 9.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.8 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.2 | 7.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 3.0 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 1.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 11.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 3.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 3.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 5.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 2.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 139.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 2.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 3.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 1.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 17.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 0.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.2 | 1.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 1.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 2.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 4.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 10.7 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 5.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 12.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 3.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 2.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 19.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 2.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 2.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 33.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 6.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 22.2 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 7.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 6.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 2.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 2.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 6.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 22.7 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 7.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 5.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 5.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 2.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.1 | 12.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 3.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 6.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.9 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 15.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) fatty acid ligase activity(GO:0015645) decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.0 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.0 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 1.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 2.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 1.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 1.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.6 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 163.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.6 | 87.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.5 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.2 | 61.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.2 | 54.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.8 | 23.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 35.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.7 | 61.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.7 | 7.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.7 | 30.3 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 50.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.6 | 27.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 24.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 66.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 14.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 7.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 11.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 9.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 7.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 19.8 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 27.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 5.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 10.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 20.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 3.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 14.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 14.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 50.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 2.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 4.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 3.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 8.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 13.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 5.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 3.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 9.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 3.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 24.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 3.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 57.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.8 | 66.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.5 | 17.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.7 | 41.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.7 | 44.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.6 | 28.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.6 | 17.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.4 | 77.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.0 | 26.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.0 | 31.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 29.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.9 | 48.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.9 | 15.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.8 | 17.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.8 | 8.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.8 | 87.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.8 | 37.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 12.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 10.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 31.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.7 | 6.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 18.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 14.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 10.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.5 | 17.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 12.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.5 | 20.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 9.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 7.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 7.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 15.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 12.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 4.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 4.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 89.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 6.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 1.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 4.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 16.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 5.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 12.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 6.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 5.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 6.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 8.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 7.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 8.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 5.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 4.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 6.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 3.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.6 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 8.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 19.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 5.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 7.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 14.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 4.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 4.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 3.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 4.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 14.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 4.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 6.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 3.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 7.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 9.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 14.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 5.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 1.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 8.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |